Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BIIB
Stock Latest News
Company Announcements
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment?
14h ago
BIIB
Premium
Ratings
Biogen’s Strong Performance and Growth Prospects in Alzheimer’s Treatment Justify Buy Rating
1d ago
BIIB
Premium
Ratings
Biogen’s Strong Financial Performance and Strategic Pipeline Drive Buy Rating
4d ago
BIIB
Premium
Ratings
Biogen’s Mixed Prospects: Hold Rating Amid Growth and Technological Challenges
4d ago
BIIB
Premium
Ratings
Biogen’s Strategic Pipeline Diversification and Promising Product Performance Drive Buy Rating
4d ago
BIIB
Premium
Ratings
Biogen’s Strong Q2 2025 Results Overshadowed by One-Time Gains and Competitive Challenges: Hold Rating Maintained
4d ago
BIIB
Premium
Company Announcements
Biogen Inc. Earnings Call Highlights Strong Growth and Raised Guidance
6d ago
BIIB
Premium
Company Announcements
Biogen’s New Study on Vumerity: Potential Market Impact
7d ago
BIIB
Premium
Company Announcements
Biogen’s Phase 3 Trial on Felzartamab: A Potential Game-Changer for Kidney Transplant Recipients
7d ago
BIIB
Premium
The Fly
Biogen price target raised to $219 from $208 at RBC Capital
7d ago
BIIB
Premium
The Fly
Biogen price target lowered to $142 from $143 at BofA
7d ago
BIIB
Premium
Ratings
Promising Developments in Biogen’s IgAN Treatments Drive Buy Rating
7d ago
BIIB
Premium
The Fly
Biogen price target raised to $135 from $125 at Citi
7d ago
BIIB
Premium
The Fly
Biogen price target raised to $194 from $187 at H.C. Wainwright
7d ago
BIIB
Premium
Ratings
Cautious Hold on Biogen Amid Modest Growth Prospects and Uncertain Pipeline
7d ago
BIIB
Premium
Company Announcements
Biogen Reports Strong Q2 2025 Results, Raises Guidance
7d ago
BIIB
Premium
The Fly
Biogen price target lowered to $144 from $146 at Morgan Stanley
7d ago
BIIB
Premium
Company Announcements
Biogen’s Litifilimab Study: A Long-Term Hope for Lupus Treatment
8d ago
BIIB
Premium
The Fly
Morning Movers: Roblox skyrockets following second quarter results
8d ago
K
CI
Premium
Ratings
Biogen’s Strong Performance and Positive Outlook Drive Buy Rating
8d ago
BIIB
Premium
The Fly
Biogen reports Q2 adjusted EPS $5.47, consensus $3.87
8d ago
BIIB
Premium
The Fly
Biogen raises FY25 adjusted EPS view to $15.50-$16.00 from $14.50-$15.50
8d ago
BIIB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
